Cooperation Partners

Medicines for Malaria Venture

Swiss BioQuant AG and MMV enters into a cooperation contract where Swiss BioQuant was selected as a preferred provider for bioanalytical services.


MMV, a not-for-profit public-private partnership, was established as a foundation in Switzerland in 1999.

The mission of MMV is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs.

The vision of MMV is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.